Verition Fund Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$738K Sell
4,000
-2,000
-33% -$435K ﹤0.01% 1508
2026
Q2
$1.47M Buy
+6,000
New +$1.3M 0.01% 1259
2026
Q1
– Sell
-3,409
Closed -$623K – 2338
2025
Q4
$623K Buy
3,409
+1,420
+71% +$198K ﹤0.01% 2494
2025
Q3
$242K Buy
+1,989
New +$224K ﹤0.01% 3398
2025
Q2
– Sell
-28,998
Closed -$3.38M – 3632
2025
Q1
$3.38M Buy
28,998
+23,650
+442% +$2.69M 0.02% 1175
2024
Q4
$452K Buy
+5,348
New +$492K ﹤0.01% 2543
2023
Q2
– Sell
-9,316
Closed -$575K – 2206
2023
Q1
$575K Buy
+9,316
New +$612K 0.01% 1162
2022
Q4
– Sell
-10,943
Closed -$488K – 2145
2022
Q3
$488K Buy
+10,943
New +$547K 0.01% 1904
2020
Q2
– Sell
-33,200
Closed -$1.95M – 1052
2020
Q1
$1.95M Buy
+33,200
New +$2.71M 0.08% 172

Other funds holding AXSM

Verition Fund Management's AXSM Position: Q3 2026 in Review

Verition Fund Management reduced its Axsome Therapeutics (AXSM) stake by 33% in Q3 2026, selling an estimated $435K and leaving 4,000 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Verition Fund Management first reported a position in AXSM in Q1 2020 and has held it in 9 quarters since. The position peaked at $3.38M in Q1 2025. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Verition Fund Management held 4,000 shares of Axsome Therapeutics worth $738K as of Q3 2026.
  • Verition Fund Management sold 2,000 Axsome Therapeutics shares in Q3 2026, an estimated $435K.
  • Axsome Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q3 2026, its #1508 holding.
  • Verition Fund Management first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 9 quarters since.
  • Verition Fund Management's Axsome Therapeutics position peaked at $3.38M in Q1 2025.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.